These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24975222)

  • 41. Tanshinone IIA blocks epithelial-mesenchymal transition through HIF-1α downregulation, reversing hypoxia-induced chemotherapy resistance in breast cancer cell lines.
    Fu P; Du F; Chen W; Yao M; Lv K; Liu Y
    Oncol Rep; 2014 Jun; 31(6):2561-8. PubMed ID: 24737252
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T; Cui L; Wang H; Wang H; Han N
    J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibitory effects of 17β-estradiol or a resveratrol dimer on hypoxia-inducible factor-1α in genioglossus myoblasts: Involvement of ERα and its downstream p38 MAPK pathways.
    Li Y; Liu Y; Lu Y; Zhao B
    Int J Mol Med; 2017 Nov; 40(5):1347-1356. PubMed ID: 28901388
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
    Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
    FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.
    Laughner E; Taghavi P; Chiles K; Mahon PC; Semenza GL
    Mol Cell Biol; 2001 Jun; 21(12):3995-4004. PubMed ID: 11359907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
    Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
    Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HIF-1α Promotes Breast Cancer Cell MCF-7 Proliferation and Invasion Through Regulating miR-210.
    Zhang Y; Yan J; Wang L; Dai H; Li N; Hu W; Cai H
    Cancer Biother Radiopharm; 2017 Oct; 32(8):297-301. PubMed ID: 29053417
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective ETAR antagonist atrasentan inhibits hypoxia-induced breast cancer cell invasion.
    Smollich M; Götte M; Kersting C; Fischgräbe J; Kiesel L; Wülfing P
    Breast Cancer Res Treat; 2008 Mar; 108(2):175-82. PubMed ID: 17468950
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of hypoxia-inducible factor-1alpha silencing on the sensitivity of human brain glioma cells to doxorubicin and etoposide.
    Chen L; Feng P; Li S; Long D; Cheng J; Lu Y; Zhou D
    Neurochem Res; 2009 May; 34(5):984-90. PubMed ID: 18937067
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast.
    Doublier S; Belisario DC; Polimeni M; Annaratone L; Riganti C; Allia E; Ghigo D; Bosia A; Sapino A
    BMC Cancer; 2012 Jan; 12():4. PubMed ID: 22217342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
    Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
    Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Knockdown of hypoxia-inducible factor-1 alpha reduces proliferation, induces apoptosis and attenuates the aggressive phenotype of retinoblastoma WERI-Rb-1 cells under hypoxic conditions.
    Xia T; Cheng H; Zhu Y
    Ann Clin Lab Sci; 2014; 44(2):134-44. PubMed ID: 24795051
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel resveratrol analogue, HS-1793, inhibits hypoxia-induced HIF-1α and VEGF expression, and migration in human prostate cancer cells.
    Kim DH; Hossain MA; Kim MY; Kim JA; Yoon JH; Suh HS; Kim GY; Choi YH; Chung HY; Kim ND
    Int J Oncol; 2013 Dec; 43(6):1915-24. PubMed ID: 24100602
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells.
    Lau CK; Yang ZF; Ho DW; Ng MN; Yeoh GC; Poon RT; Fan ST
    Clin Cancer Res; 2009 May; 15(10):3462-71. PubMed ID: 19447872
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suppression of the doxorubicin response by hypoxia-inducible factor-1α is strictly dependent on oxygen concentrations under hypoxic conditions.
    Osada-Oka M; Kuwamura H; Imamiya R; Kobayashi K; Minamiyama Y; Takahashi K; Tanaka M; Shiota M
    Eur J Pharmacol; 2022 Apr; 920():174845. PubMed ID: 35202675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evodiamine represses hypoxia-induced inflammatory proteins expression and hypoxia-inducible factor 1alpha accumulation in RAW264.7.
    Liu YN; Pan SL; Liao CH; Huang DY; Guh JH; Peng CY; Chang YL; Teng CM
    Shock; 2009 Sep; 32(3):263-9. PubMed ID: 19106818
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of hypoxia on the chemotherapeutic sensitivity of human ovarian cancer cells to paclitaxel and its mechanism].
    Huang L; Zhang QH; Ao QL; Xing H; Lu YP; Ma D
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):96-100. PubMed ID: 17645840
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structure-activity relationship of resveratrol and its analogue, 4,4'-dihydroxy-trans-stilbene, toward the endothelin axis in human endothelial cells.
    Coppa T; Lazzè MC; Cazzalini O; Perucca P; Pizzala R; Bianchi L; Stivala LA; Forti L; Maccario C; Vannini V; Savio M
    J Med Food; 2011 Oct; 14(10):1173-80. PubMed ID: 21554123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of an interactive tumor vascular suppression strategy to inhibit multidrug resistance and metastasis with pH/H
    Du B; Ding X; Wang H; Du Q; Xu T; Huang J; Zhou J; Cheng G
    J Mater Chem B; 2019 Aug; 7(31):4784-4793. PubMed ID: 31389949
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel hypoxia response element regulates oxygen-related repression of tissue factor pathway inhibitor in the breast cancer cell line MCF-7.
    Cui XY; Skretting G; Tinholt M; Stavik B; Dahm AEA; Sahlberg KK; Kanse S; Iversen N; Sandset PM
    Thromb Res; 2017 Sep; 157():111-116. PubMed ID: 28734156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.